Dominique Bonnet and Frederic Relaix join the Stem Cell Reports editorial team, adding expertise in hematopoietic ...

The 4th GANSID Congress 2026 concluded after three days of discussions on inherited blood disorders. Delegates from 23 countries examined prevention, early diagnosis, equitable healthcare access, bone ...

A Salmon man on hospice care is raising money “one slice at a time” for ALS research after his wife was diagnosed with the ...

Researchers are exploring new options for patients with relapsed or refractory hairy cell leukemia, including chimeric ...

Even as a medical student, Dr. David Fajgenbaum took the “physician, heal thyself” adage literally. It saved his life.

Vicksburg teenager battling a rare genetic disorder is preparing for a major step in his medical journey as he becomes ...

After more than 100 hospitalizations, Phillip Mullin’s gene therapy milestone offers new hope amid longstanding racial disparities and decades of sickle cell research.

Bone disorders impact millions of people, but new research suggests quality of life could be improved by taking a natural extract from French maritime pine bark.

Phillip Mullin, who has been hospitalized more than 100 times because of the disease, rang a bell Friday to celebrate the ...

Researchers report that the microRNA miR-21a-5p protects the injured blood–brain barrier in cellular models by directly ...

About TALZENNA® (talazoparib) TALZENNA is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair. Preclinical studies have demonstrated that TALZENNA blocks ...

BPDCN: Frontline Tagraxofusp Produces Responses, but Durable Remission Tracks With Transplant / Blastic Plasmacytoid ...